Exact Sciences Nets $138M in Stock Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences has raised $137.7 million in net proceeds from a public offering of 11.5 million shares of common stock.

The firm priced the shares at $12.75 each, which brought in gross proceeds of $146.6 million. Exact Sciences priced the offering of 10 million shares last week. The underwriters on the offering exercised their 1.5 million-share overallotment option in full.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.